'Exciting' Lung Cancer Drug Approved for CDF - Medscape

'Exciting' Lung Cancer Drug Approved for CDF  Medscape

Approval for CDF inclusion of 'exciting' immunotherapy drug durvalumab for some lung cancer patients was among this week's announcements by NICE.



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Respirology | APSR Respiratory Medicine Journal